haloperidol has been researched along with 1-hydroxy-3-amino-2-pyrrolidone in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Bonta, IL; Dzoljić, MR; Godschalk, M; Lagendijk, A; Stefanko, S | 1 |
| Waldmeier, PC | 1 |
| Belfroid, RD; Heerkens, CB; Van der Krogt, JA; Van Valkenburg, CF | 1 |
| Danysz, W; Kretschmer, BD; Schmidt, WJ; Winterscheid, B | 1 |
| Furuya, Y; Kagaya, T; Nishizawa, Y; Ogura, H | 1 |
| Connelly, ST; Shepard, PD | 1 |
7 other study(ies) available for haloperidol and 1-hydroxy-3-amino-2-pyrrolidone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
EEG-synchronizing effect of gamma-hydroxybutyrate and 1-hydroxy-3-amino-pyrrolidone-2 (HA-966) in relation to dopaminergic brain function.
Topics: Acoustic Stimulation; Animals; Behavior, Animal; Brain; Catecholamines; Cortical Synchronization; Depression, Chemical; Ditiocarb; Dopamine; Electroencephalography; Fenclonine; Haloperidol; Hydroxybutyrates; Methyltyrosines; Pyrrolidinones; Rats; Substantia Nigra; Time Factors | 1975 |
The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis.
Topics: 4-Butyrolactone; Animals; Baclofen; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; GABA-A Receptor Antagonists; Haloperidol; Organophosphorus Compounds; Pyrrolidinones; Rats; Tetrabenazine | 1991 |
Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Tolerance; Haloperidol; Homovanillic Acid; Male; Pyrrolidinones; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1988 |
Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats.
Topics: Animals; Benzazepines; Catalepsy; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Kynurenic Acid; Male; Motor Activity; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate | 1994 |
Differential effects of the strychnine-insensitive glycine site antagonist (+)-HA-966 on the hyperactivity and the disruption of prepulse inhibition induced by phencyclidine in rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Dopamine Agonists; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Haloperidol; Hyperkinesis; Male; Motor Activity; Phencyclidine; Pyrrolidinones; Rats; Rats, Wistar; Reflex, Startle; Strychnine | 1998 |
Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent, S(-)HA-966 without affecting the basal firing properties of dopamine neurons.
Topics: Action Potentials; Animals; Apomorphine; Denervation; Dopamine; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; GABA-B Receptor Antagonists; Haloperidol; Male; Neurons; Pertussis Toxin; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Substantia Nigra; Virulence Factors, Bordetella | 1999 |